0

High Throughput Screening Market by End-user and Geography - Forecast and Analysis 2021-2025

  • Published: Aug 2021
  • Pages: 120
  • SKU: IRTNTR44564
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The high throughput screening (HTS) market share is expected to increase by USD 11.10 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 7.83%.

This high throughput screening (HTS) market research report provides valuableHTS into the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers high throughput screening (HTS) market segmentation by end-user (pharmaceutical and biotechnology companies, academic and research institutes, and CROs) and geography (North America, Europe, Asia, and ROW). The high throughput screening (HTS) market report also offers information on several market vendors, including Agilent Technologies Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, and Thermo Fisher Scientific Inc. among others.

What will the High Throughput Screening (HTS) Market Size be During the Forecast Period?

High Throughput Screening (HTS) Market Size

Download Report Sample to Unlock the High Throughput Screening (HTS) Market Size for the Forecast Period and Other Important Statistics

 

High Throughput Screening (HTS) Market: Key Drivers, Trends, and Challenges

The rise in R&D investments is notably driving the high throughput screening (HTS) market growth, although factors such as the high cost of the drug discovery process and limitations of HTS may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the high throughput screening (HTS) industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key High Throughput Screening (HTS) Market Driver

The rise in R&D investments is one of the major drivers impacting the high throughput screening (HTS) market growth. The global expenditure on R&D for drug development has shown constant growth in the last few years. With growing economies, the developing countries are expected to focus on the disease burden. This will lead to the setting up of a large number of laboratories and research facilities/centers in these countries during the forecast period. In 2019, the investment in R&D by pharmaceutical companies was more than $370 billion in the US, and this trend is expected to continue during the forecast period. For instance, around 12 big pharmaceutical companies in the world collectively spent $82 billion on drug development in 2018. In 2019, Novartis spent around 2.8 billion in Innovative Medicines Division research and exploratory development, which increased by 3% compared to 2018. Thus, rising investments in R&D have resulted in an increase in drug discoveries by availing the benefits offered by HTS. Compared with traditional drug screening methods, HTS is characterized by its simplicity, rapid results, low cost, and high efficiency.

Key High Throughput Screening (HTS) Market Trend

Growth in outsourcing activities is one of the major trends influencing the high throughput screening (HTS) market growth. Many pharmaceutical and biotechnology companies outsource drug discovery and research activities to CROs and research institutes, which helps to reduce manufacturing and distribution costs, ensures the quality of research, and reduces lead times. It also helps the sourcing companies to concentrate on other competencies such as pricing and marketing strategies and brand building. This factor is increasing the number of CROs providing HTS services. Some of the CROs providing HTS services are listed below: Charles River Laboratories: It offers a screening platform for the identification of hit compounds. It delivers validated hit compounds from more than 20 HTS campaigns per year.GVK Biosciences: It offers HTS for cell-based assays and biochemicals against target classes such as G protein-coupled receptors (GPCR), transporters, ion channels, and enzymes. It performs HTS on assay panels for a novel target. The company has completed several HTS campaigns that include over 4,00,000 compound screenings. This trend is expected to lead to market growth in these regions.

Key High Throughput Screening (HTS) Market Challenge

The high cost of the drug discovery process and the limitations of HTS are one of the major challenges impeding the high throughput screening (HTS) market growth. Drug research and development is an expensive process that requires an investment of billions of dollars. Pharmaceutical companies spend $0.5 million to $1.5 million or more for just one API early development. HTS is used in drug lead identification, which helps in identifying new candidates of drug molecules for further drug development. The high cost of drug discovery limits the entry of new players into the pharmaceutical industry. Additionally, many critical properties for the development of a successful drug are not assessed by HTS. For instance, HTS is unable to evaluate domains such as bioavailability, pharmacokinetics, toxicity, and absolute specificity. Pharmacological and medicinal chemistry studies are required to convert a compound, that emerges from HTS, into a useful drug. Thus, the high cost of the drug discovery process, coupled with limiting the use of HTS, is likely to hamper the growth of the market.

This high throughput screening (HTS) market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the high throughput screening (HTS) market as a part of the life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the high throughput screening (HTS) market during the forecast period.

Who are the Major High Throughput Screening (HTS) Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Agilent Technologies Inc.
  • Beckman Coulter Inc.
  • Bio Rad Laboratories Inc.
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

 

This statistical study of the high throughput screening (HTS) market encompasses successful business strategies deployed by the key vendors. The high throughput screening (HTS) market is fragmented and the vendors are deploying growth strategies such as expanding their product portfolios by developing advanced technologies and gaining regulatory approvals for their new products to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The high throughput screening (HTS) market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

High Throughput Screening (HTS) Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the high throughput screening (HTS) market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the life sciences tools and services market includes the following core components:

  • Inputs
  • Inbound logistics
  • Operations
  • Outbound logistics
  • Marketing and sales
  • Service
  • Support activities
  • Innovation

The report has further elucidated other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

 

Which are the Key Regions for High Throughput Screening (HTS) Market?

High Throughput Screening (HTS) Market Share by Geography

For more insigHTS on the market share of various regions Request PDF Sample now!

40% of the market’s growth will originate from North America during the forecast period. The US is a key market for high throughput screening in North America. However, the market growth rate in North America will be slower than the growth of the market in Asia and Europe.

The presence of large pharmaceutical companies and well-established research centers will facilitate the high throughput screening market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 had a positive impact on the growth of the HTS market in the region. The growing adoption of HTS in identifying the potential candidate for COVID-19 therapeutics increased its demand among end-users. For instance, in July 2020, scientists at HTS Center in Southern Research in the US screened numerous compound samples to identify agents that could become a new treatment for COVID-19 using HTS. Thus, the demand for HTS will increase during the forecast period due to the outbreak of COVID-19 in the region. Furthermore, the presence of large pharmaceutical companies and well-established research centers are further expected to drive the regional market in focus during the forecast period.

What are the Revenue-generating End User Segments in the High Throughput Screening (HTS) Market?

High Throughput Screening (HTS) Market Share

To gain further insigHTS into the market contribution of various segments Request PDF Sample

The high throughput screening market share growth by the pharmaceutical and biotechnology companies segment will be significant during the forecast period. Rising pharmaceutical spending, coupled with the increase in demand for HTS for identifying and screening new drug molecules, will propel the demand for HTS in the pharmaceutical and biotechnology companies segment. The prime goal of HTS is to accelerate the drug discovery process by screening a large number of compound libraries for lead identification and optimization. Thus, increased usage of HTS technology by pharmaceutical and biotechnology companies will increase the demand for HTS, thus benefiting the market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the HTS market size and actionable market insights on post COVID-19 impact on each segment.

 

High Throughput Screening (HTS) Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 7.83%

Market growth 2021-2025

$ 11.10 billion

Market structure

Fragmented

YoY growth (%)

7.15

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 40%

Key consumer countries

US, Germany, Japan, France, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agilent Technologies Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this High Throughput Screening (HTS) Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive high throughput screening (HTS) market growth during the next five years
  • Precise estimation of the high throughput screening (HTS) market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the high throughput screening (HTS) industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of high throughput screening (HTS) market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 01: Parent market
    • Exhibit 02: Market characteristics
  • 2.2 Value chain analysis
    • Exhibit 03: Value chain analysis: Life science tools and services

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 04: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 05: Market segments
  • 3.3 Market size 2020
    • 3.4 Market outlook: Forecast for 2020 - 2025
      • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
      • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 08: Five forces analysis 2020 & 2025
    • 4.2 Bargaining power of buyers
      • Exhibit 09: Bargaining power of buyers
    • 4.3 Bargaining power of suppliers
      • Exhibit 10: Bargaining power of suppliers
    • 4.4 Threat of new entrants
      • Exhibit 11: Threat of new entrants
    • 4.5 Threat of substitutes
      • Exhibit 12: Threat of substitutes
    • 4.6 Threat of rivalry
      • Exhibit 13: Threat of rivalry
    • 4.7 Market condition
      • Exhibit 14: Market condition - Five forces 2020

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • Exhibit 15: End-user - Market share 2020-2025 (%)
    • 5.2 Comparison by End-user
      • Exhibit 16: Comparison by End-user
    • 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2020-2025
      • Exhibit 17: Pharmaceutical and biotechnology companies - Market size and forecast 2020-2025 ($ million)
      • Exhibit 18: Pharmaceutical and biotechnology companies - Year-over-year growth 2020-2025 (%)
    • 5.4 Academic and research institutes - Market size and forecast 2020-2025
      • Exhibit 19: Academic and research institutes - Market size and forecast 2020-2025 ($ million)
      • Exhibit 20: Academic and research institutes - Year-over-year growth 2020-2025 (%)
    • 5.5 CROs - Market size and forecast 2020-2025
      • Exhibit 21: CROs - Market size and forecast 2020-2025 ($ million)
      • Exhibit 22: CROs - Year-over-year growth 2020-2025 (%)
    • 5.6 Market opportunity by End-user
      • Exhibit 23: Market opportunity by End-user

    6 Customer landscape

    • 6.1 Overview
      • Exhibit 24: Customer landscape

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 25: Market share by geography 2020-2025 (%)
    • 7.2 Geographic comparison
      • Exhibit 26: Geographic comparison
    • 7.3 North America - Market size and forecast 2020-2025
      • Exhibit 27: North America - Market size and forecast 2020-2025 ($ million)
      • Exhibit 28: North America - Year-over-year growth 2020-2025 (%)
    • 7.4 Europe - Market size and forecast 2020-2025
      • Exhibit 29: Europe - Market size and forecast 2020-2025 ($ million)
      • Exhibit 30: Europe - Year-over-year growth 2020-2025 (%)
    • 7.5 Asia - Market size and forecast 2020-2025
      • Exhibit 31: Asia - Market size and forecast 2020-2025 ($ million)
      • Exhibit 32: Asia - Year-over-year growth 2020-2025 (%)
    • 7.6 ROW - Market size and forecast 2020-2025
      • Exhibit 33: ROW - Market size and forecast 2020-2025 ($ million)
      • Exhibit 34: ROW - Year-over-year growth 2020-2025 (%)
    • 7.7 Key leading countries
      • Exhibit 35: Key leading countries
    • 7.8 Market opportunity by geography
      • Exhibit 36: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • Exhibit 37: Impact of drivers and challenges
      • 8.3 Market trends

        9 Vendor Landscape

        • 9.1 Overview
          • Exhibit 38: Vendor landscape
        • 9.2 Landscape disruption
          • Exhibit 39: Landscape disruption
          • Exhibit 40: Industry risks

        10 Vendor Analysis

        • 10.1 Vendors covered
          • Exhibit 41: Vendors covered
        • 10.2 Market positioning of vendors
          • Exhibit 42: Market positioning of vendors
        • 10.3 Agilent Technologies Inc.
          • Exhibit 43: Agilent Technologies Inc. - Overview
          • Exhibit 44: Agilent Technologies Inc. - Business segments
          • Exhibit 45: Agilent Technologies Inc. - Key News
          • Exhibit 46: Agilent Technologies Inc. - Key offerings
          • Exhibit 47: Agilent Technologies Inc. - Segment focus
        • 10.4 Beckman Coulter Inc.
          • 10.5 Bio Rad Laboratories Inc.
            • Exhibit 52: Bio Rad Laboratories Inc. - Overview
            • Exhibit 53: Bio Rad Laboratories Inc. - Business segments
            • Exhibit 54: Bio Rad Laboratories Inc. - Key offerings
            • Exhibit 55: Bio Rad Laboratories Inc. - Segment focus
          • 10.6 Charles River Laboratories International Inc.
            • Exhibit 56: Charles River Laboratories International Inc. - Overview
            • Exhibit 57: Charles River Laboratories International Inc. - Business segments
            • Exhibit 58: Charles River Laboratories International Inc. - Key offerings
            • Exhibit 59: Charles River Laboratories International Inc. - Segment focus
          • 10.7 Corning Inc.
            • Exhibit 60: Corning Inc. - Overview
            • Exhibit 61: Corning Inc. - Business segments
            • Exhibit 62: Corning Inc. - Key offerings
            • Exhibit 63: Corning Inc. - Segment focus
          • 10.8 Danaher Corp.
            • Exhibit 64: Danaher Corp. - Overview
            • Exhibit 65: Danaher Corp. - Business segments
            • Exhibit 66: Danaher Corp. - Key News
            • Exhibit 67: Danaher Corp. - Key offerings
            • Exhibit 68: Danaher Corp. - Segment focus
          • 10.9 Eurofins Scientific SE
            • Exhibit 69: Eurofins Scientific SE - Overview
            • Exhibit 70: Eurofins Scientific SE - Business segments
            • Exhibit 71: Eurofins Scientific SE - Key News
            • Exhibit 72: Eurofins Scientific SE - Key offerings
            • Exhibit 73: Eurofins Scientific SE - Segment focus
          • 10.10 F. Hoffmann-La Roche Ltd.
            • Exhibit 74: F. Hoffmann-La Roche Ltd. - Overview
            • Exhibit 75: F. Hoffmann-La Roche Ltd. - Business segments
            • Exhibit 76: F. Hoffmann-La Roche Ltd. - Key offerings
            • Exhibit 77: F. Hoffmann-La Roche Ltd. - Segment focus
          • 10.11 Merck KGaA
            • Exhibit 78: Merck KGaA - Overview
            • Exhibit 79: Merck KGaA - Business segments
            • Exhibit 80: Merck KGaA - Key News
            • Exhibit 81: Merck KGaA - Key offerings
            • Exhibit 82: Merck KGaA - Segment focus
          • 10.12 Thermo Fisher Scientific Inc.
            • Exhibit 83: Thermo Fisher Scientific Inc. - Overview
            • Exhibit 84: Thermo Fisher Scientific Inc. - Business segments
            • Exhibit 85: Thermo Fisher Scientific Inc. - Key News
            • Exhibit 86: Thermo Fisher Scientific Inc. - Key offerings
            • Exhibit 87: Thermo Fisher Scientific Inc. - Segment focus

          11 Appendix

          • 11.1 Scope of the report
            • 11.2 Currency conversion rates for US$
              • Exhibit 88: Currency conversion rates for US$
            • 11.3 Research methodology
              • Exhibit 89: Research Methodology
              • Exhibit 90: Validation techniques employed for market sizing
              • Exhibit 91: Information sources
            • 11.4 List of abbreviations
              • Exhibit 92: List of abbreviations

            Research Framework

            Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

            TechnavioINFORMATION SOURCES

            Primary sources

            • Manufacturers and suppliers
            • Channel partners
            • Industry experts
            • Strategic decision makers

            Secondary sources

            • Industry journals and periodicals
            • Government data
            • Financial reports of key industry players
            • Historical data
            • Press releases
            Technavio

            TechnavioDATA ANALYSIS

            Data Synthesis

            • Collation of data
            • Estimation of key figures
            • Analysis of derived insights

            Data Validation

            • Triangulation with data models
            • Reference against proprietary databases
            • Corroboration with industry experts
            Technavio

            TechnavioREPORT WRITING

            Qualitative

            • Market drivers
            • Market challenges
            • Market trends
            • Five forces analysis

            Quantitative

            • Market size and forecast
            • Market segmentation
            • Geographical insights
            • Competitive landscape
            Interested in this report?
            Get your sample now!
            High Throughput Screening (HTS) Market market growth will increase by $11.10 bn during 2021-2025.
            The high throughput screening (hts) market market is expected to grow at a CAGR of 7.83% during 2021-2025.
            Technavio has segmented the high throughput screening (hts) market market by end user (pharmaceutical and biotechnology companies, academic and research institutes, and CROs) ,geography (North America, Europe, Asia, and ROW) , and geographic (North America, Europe, Asia, and ROW).
            Agilent Technologies Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. are a few of the key vendors in the high throughput screening (hts) market market.
            North America will register the highest growth rate of 40% among the other regions. Therefore, the high throughput screening (hts) market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
            The key factors driving the high throughput screening (hts) market market growth are:
            • Rise in R&D investments
            • Increasing focus on promotional activities
            The high throughput screening (hts) market market vendors should focus on grabbing business opportunities from the pharmaceutical and biotechnology companies segment as it accounted for the largest market share in the base year.
            • What are the key global market and the regional market share?
            • What are the revenue-generating key market segments?
            • What are the key factors driving and challenging this market’s growth?
            • Who are the key market vendors and their growth strategies?
            • What are the latest trends influencing the growth of this market?
            • What are the variables influencing the market growth in the primary regions?
            • What are the factors influencing the growth of the parent market?
            • Off-the-shelf research reports
            • Reports can be tailored to meet the customer's needs
            • Trusted by more than 100 fortune 500 organizations
            • Information about the market's key drivers, trends, and challenges
            • Parent market analysis
            • Every week, 50,000 people visit our subscription platform
            • Detailed vendors report with competitive landscape
            • Covid-19 impact and recovery analysis
            • Data on revenue-generating market segments
            • Details on the market shares of various regions
            • Five-force market analysis

            Certified ISO 9001 : 2015

            We are ISO recognized

            We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

            We are GDPR and CCPA compliant

            We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

            Safe and Secure SSL Encrypted
            Technavio

            info
            close
            • Single:

              One user only.
              Quick & easy download option

            • Enterprise:

              Unlimited user access (Within your organization)
              Complimentary Customization Included

            2500 USD

            Technavio Get the report (PDF) sent to your email within minutes.

            Subscribe & Save

            Get lifetime access to our
            Technavio Insights

            Customized Report as per your Business Needs

            • Our analysts will work directly with you and understand your needs
            • Get data on specified regions or segments, competitor and Vendors
            • Data will be formatted and presented as per your requirements
            • We offer $1000 worth of FREE customization at the time of purchase

            Let us help you make report more suited to your requirements.

            • Get a competitive breakdown as per your niche industry
            • Customize the data with various metrics that meet your business prerequisite
            • Understand Revenue Sources, Customers and many more
            • Details on Market Share
            • These customizations are done in a short amount of time by our analysts and industry experts
            Technavio
            Enquire Before Buying
            17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>